The organization of cellular niches is known to have a key role in regulating normal stem cell differentiation and regeneration, but relatively little is known about the architecture of microenvironments that support malignant metastasis 1,2 . Using dynamic in vivo confocal imaging, here we show that murine bone marrow contains unique anatomic regions defined by specialized endothelium. This vasculature expresses the adhesion molecule E-selectin and the chemoattractant stromal-cell-derived factor 1 (SDF-1) in discrete, discontinuous areas that influence the homing of a variety of tumour cell lines. Disruption of the interactions between SDF-1 and its receptor CXCR4 inhibits the homing of Nalm-6 cells (an acute lymphoblastic leukaemia cell line) to these vessels. Further studies revealed that circulating leukaemic cells can engraft around these vessels, suggesting that this molecularly distinct vasculature demarcates a microenvironment for early metastatic tumour spread in bone marrow. Finally, purified haematopoietic stem/progenitor cells and lymphocytes also localize to the same microdomains, indicating that this vasculature might also function in benign states to demarcate specific portals for the entry of cells into the marrow space. Specialized vascular structures therefore appear to delineate a microenvironment with unique physiology that can be exploited by circulating malignant cells.
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It is thought that tumour cells derive their ability to transit to specific organs by co-opting the same tissue-homing mechanisms used by benign leukocytes 3 . Substantial in vitro and more limited in vivo data provide evidence that tumour cells depend on selectin-, integrin-, and chemokine-mediated vascular cell adhesion events in order to identify and bind to vascular beds at sites of tissue entry 4, 5 . These molecular mechanisms are thought to enable the efficient spread of malignancies to target organs. Differential expression of endothelial signals among tissues is known to control the destination of cellular traffic, but the contributions of the vascular molecular framework to the regulation of complex cellular microenvironments remain to be fully elucidated.
The bone marrow is a common site for the spread of solid tumours. It can also be considered a ubiquitous site for leukaemic cell metastasis, as disease is seen to migrate from the initial birthplace of the leukaemic clone to marrow spaces in distant sites throughout the body. These observations suggest that bone marrow provides a favourable environment for circulating tumour lodgement and growth. Moreover, the bone marrow is commonly the source of latent or 'minimal residual disease' following treatment, raising the possibility that specific anti-apoptotic 'niches' for metastatic growth might exist. Understanding the biological architecture of this host microenvironment therefore has important implications for our approach to tumour treatment.
Although a variety of in vitro and in vivo techniques exist to study cell transit through the bone marrow, they are limited in their ability to assess the spatial and temporal relationship of cells. To examine the dynamic interactions between intravenously injected tumour cells and the bone marrow microenvironment, we imaged fluorescently labelled cells using in vivo confocal microscopy. As the cortex of the mouse skull is relatively thin, imaging of the underlying bone marrow can be performed on the skull with minimal manipulation 6 . Furthermore, the calvarium and other flat bones constitute a large bone marrow compartment, contributing approximately 45% of the hematopoietically active marrow in the adult 7 . In our initial experiments, we sought to test the hypothesis that leukaemic cells interact with the vascular endothelium in a manner that mimics the multi-step tissue-homing mechanisms of their benign leukocyte counterparts 8 . Progressive scanning and optical sectioning through the bone marrow revealed the existence of unique, spatially restricted vascular domains, at which the majority of marrow-homing Nalm-6 pre-B acute lymphoblastic leukaemia (ALL) cells arrested (Fig. 1a, b) . Using video-rate imaging, we observed that leukaemic cells roll along and bind this endothelium minutes after injection (see Supplementary Videos 1-4) . Serial imaging of mice on days 3, 10 ( Fig. 1c, d ) and 14 (data not shown) showed that Nalm-6 cells diapedesed at these sites and increased in numbers in these perivascular locations. This localization of tumour cells to specific regions was not restricted to Nalm-6 cells. Other cell lines, including human (Reh and RS4;11) and murine (300-19) leukaemias, as well as multiple myeloma (U266) and solid tumours (MatLyLu prostatic carcinoma) homed to the same vascular microdomains (see Supplementary Fig. 1 ).
Given these observations, we hypothesized that the endothelium in these bone marrow regions expresses a unique combination of vascular cell adhesion molecules and/or chemokines capable of attracting a variety of tumour metastases. We first identified the chemokine receptors expressed in common by various cell lines that homed to these regions. Quantitative studies using polymerase chain reaction with reverse transcription (RT-PCR) showed that messenger RNA for the chemokine receptors CXCR3 and CXCR4 is produced by these cells (Fig. 1e) . However, flow cytometry experiments detected no cell-surface CXCR3 receptor on Nalm-6 cells, but high levels of cell-surface CXCR4 expression were found (Fig. 1f) . In vitro transwell chemotaxis assays confirmed that Nalm-6 cells are not responsive to CXCR3 ligands, but do migrate in response to SDF-1, the only chemokine known to bind CXCR4 (Fig. 1g) . These studies defined SDF-1 as a candidate chemokine for mediating Nalm-6 homing to these vascular regions. Notably, SDF-1 is known to be involved in bone marrow engraftment for a variety of malignant tumour cells, including Nalm-6 cells (refs 9-15).
To examine SDF-1 expression within bone marrow, we performed immunoimaging of SDF-1 in vivo by labelling cell-surface antigens in situ with intravenously injected fluorescent antibodies (J.M.R., X.W., P. Zamiri, D.A.S., A. Bogdanov and C.P.L., unpublished observations). Although SDF-1 is known to be produced by bone marrow stromal cells, mediating B-lymphopoiesis and myelopoiesis in addition to functioning as a chemoattractant, little is known about SDF-1 localization within the marrow space 16, 17 . We found that SDF-1 was expressed in vascular 'hot spots', corresponding to the regions that attract leukaemic cells (Fig. 1h -j, Supplementary  Figs 2 and 3) . Most of these SDF-1-positive vessels were located parasagittally within the frontal and parietal bones. This parasagittal SDF-1-positive vasculature consisted of sinusoidal networks as well as larger venules leading into these capillary beds. Conversely, bilateral para-coronal sinusoidal networks, possessing similar size and flow characteristics as the parasagittal sinusoidal beds, were SDF-1-negative. Therefore, SDF-1 expression was not strictly dependent on vessel size or flow.
Using this immunoimaging approach, we then examined the regional distributions of various vascular cell adhesion molecules known to be expressed in bone marrow 18 . Intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), platelet/endothelial cell adhesion molecule 1 (PECAM-1) and Pselectin were expressed diffusely throughout the marrow vasculature (Fig. 2a-e) . However, the pattern of E-selectin expression corresponded to that of SDF-1, and was limited to vessels that supported leukaemic cell engraftment (Fig. 2f-l) . E-selectin localization terminated abruptly along individual venules as one moved laterally away from the central axis of the sinusoidal vasculature, again parallel to the pattern seen for SDF-1. Notably, E-selectin expression was Fig. 3 , PECAM-1/SDF-1 co-label). j, Nalm-6 cell homing to SDF-1-expressing regions in a third mouse.
dramatically demarcated, to the extent that E-selectin was expressed on only one wall of certain microvessels (Fig. 2g-i) . We confirmed these results by repeating our in vivo immunoimaging studies of PECAM-1, SDF-1 and E-selectin expression using alternative antibody clones (see Methods for details).
Together, the immunoimaging experiments suggest that specific microvascular domains in the bone marrow express high levels of both E-selectin and SDF-1. In vivo co-localization studies confirmed that Nalm-6 cell binding was restricted to these same E-selectin þ-
SDF-1
þ vessel beds (Fig. 3a-f ). These observations raise the possibility that E-selectin and/or SDF-1 regulate this restricted leukaemic cell homing.
To test this hypothesis, we evaluated the functional role of E-selectin and CXCR4-SDF-1 interactions for leukaemic homing to these specific regions. When Nalm-6 cells were injected into an E-selectin knockout mouse, we observed a ,20% reduction in their homing to bone marrow (Fig. 3g, h, k) . In contrast, when cells were pre-treated with pertussis toxin, an inhibitor of chemokine receptor Ga i -mediated signalling, homing was decreased by almost 80% (Fig. 3k) . Similar results were obtained upon CXCR4 desensitization and downregulation in response to SDF-1 ( Fig. 3k and Supplementary Fig. 4) , as well as highly specific CXCR4 receptor blockade by the small molecule inhibitor AMD3100 (ref. 19 ; Fig. 3i-k) . These data suggest that although E-selectin might serve to enhance homing, the majority of Nalm-6 cell vascular adhesion events can occur in its absence. Loss of SDF-1, however, does not appear to be compensated for by other adhesive molecules. These results also suggest that SDF-1-CXCR4 interactions, known to be important for cell retention in the marrow matrix (see also Supplementary Fig. 5 ), are pivotal at the earliest stage of tumour metastasis in the bone marrow (recognition and binding to permissive vasculature) 20 . Although this mechanism has been suggested by in vitro data, it has not previously been observed in vivo 21, 22 . We next examined whether cells that were prevented from homing to the bone marrow spread to alternative tissue compartments or remained in the peripheral circulation. To quantify leukaemic cell homing kinetics, we used in vivo flow cytometry, a new technology for detecting and counting individual, fluorescently labelled cells flowing through peripheral vessels as a function of time postinjection 23 . As shown in Fig. 3l , .70% of Nalm-6 cells exit the circulation in control mice in the first hour after injection, consistent with the rapid homing to bone marrow observed using microscopy. In contrast, ,20% of cells treated with AMD3100 exit the circulation within the first hour, suggesting that cells inhibited from bone marrow homing remain in the peripheral circulation. The cells exit the circulation with a time course consistent with when the drug effect is expected to decline 24 . Last, we explored the normal function of these vascular regions. Because SDF-1 is known to be a potent chemoattractant for haematopoietic stem/progenitor cells (HSPCs) and lymphocytes, and as blood-borne HSPCs and lymphocytes traffic to bone marrow, we hypothesized that circulating HSPCs and lymphocytes might preferentially home to these same microdomains 25, 26 . Fluorescently labelled HSPCs isolated from donor BALB/c mice were injected into recipient mice, and intravital bone marrow imaging was performed at multiple time points. Representative images taken 2 h after injection show HSPCs adherent to bone marrow microvasculature in the same restricted domains as SDF-1 vascular expression (Fig. 4a-c) . Seventy days after injection (Fig. 4d) , populations of labelled cells are still detected in the bone marrow extravascular space within these microdomains. Although we cannot exclude the possibility that the observed fluorescence signal comes from cell debris that has been ICAM-1, VCAM-1 and P-selectin are expressed throughout the bone marrow vasculature. Arrows in c indicate P-selectinpositive megakaryocytes. e, f, Montage images of extended PECAM-1 expression compared with restricted E-selectin expression (both area 3). g-i, An image series from area 4/6. The bone marrow blood pool (red) is delineated by a non-specific fluorescent antibody signal. E-selectin expression (green) is restricted to one wall of a large collecting vein and to sinusoidal microvasculature in area 4. j-l, E-selectin expression (green) corresponds with Nalm-6 cell (red) homing patterns. The vascular staining pattern is contrasted with anti-GR1 (myeloid differentiation antigen) staining of the same region (midline, intersection of areas 3-6). Scale bars in i and j, 100 mm.
phagocytosed by other cells (for example, macrophages), the morphology and persistence of dye are consistent with the engraftment of a primitive cell or stem cell pool with slow cell cycling 1 . Flow cytometry studies of cultured cells confirmed the stability of membrane dye signal in slowly dividing cells, while rapidly dividing cells diluted dye to undetectable levels after 4-5 cell divisions (see Supplementary Fig. 6 ). In another set of experiments, T lymphocytes isolated from the spleen and lymph nodes of a BALB/c mouse were labelled and injected intravenously into a SCID recipient (see Supplementary Fig. 7) . Again, cells immediately homed to the same microdomains, and were observed within these areas two weeks later. These observations suggest that benign circulating HSPCs, mature T lymphocytes and leukaemic cells use the same vascular subregions for localization in bone marrow. Whether these unique vascular domains intersect or interact with the previously defined bone marrow endosteal cellular niche for haematopoietic stem cells has not yet been defined. Whether benign and malignant cells use overlapping or distinct molecular features to identify these vascular sites is the subject of ongoing experiments; however, our preliminary data show that homing of benign T lymphocytes to the bone marrow is only minimally inhibited by AMD3100 or CXCR4 blockade. Moreover, results from other investigators suggest that treatment with AMD3100 only modestly inhibits HSPCs from homing to bone marrow 27 . Should differences in how these and other benign and malignant cells recognize bone marrow microenvironments be confirmed, they could be exploited to thwart metastasis while minimizing effects on normal bone marrow function.
It has long been believed that early micrometastases from liquid and solid tumours occur in specific anatomic compartments of the bone marrow, although no molecular basis for such regionalization has been established 28 . Although many investigations have explored the roles of various cell adhesion molecules and chemokines in cell homing to the bone marrow, studies based on traditional methods have been limited by spatial and temporal sampling restrictions. Elegant studies using bioluminescence imaging have provided temporal information, but are restricted by limitations of spatial resolution 29 . Our approach has allowed us to combine a high degree of spatial and temporal resolution with an in vivo molecular labelling technique. We have shown that the bone marrow microvasculature is comprised of functional domains that are characterized by the expression of specific vascular cell-surface adhesion molecules and chemoattractants crucial for malignant cell homing to these areas. In a benign setting, these domains also appear to define sites at which circulating haematopoietic stem/progenitor cells and lymphocytes enter the bone marrow. Of note, other molecules that are more diffusely expressed might still contribute to the localized homing and engraftment processes that we have observed. Our in vivo imaging and flow cytometry approaches should be widely ) compared with wild-type (WT) control (1 h after injection). i, j, Nalm-6 cell homing is inhibited by AMD3100 blockade of CXCR4. k, The effect of pertussis toxin (PTX) treatment, SDF-1-induced CXCR4 desensitization 30 , and AMD3100 treatment on cell homing to bone marrow microdomains. l, In vivo flow cytometry experiments show that Nalm-6 cells blocked from bone marrow homing by SDF-1-induced CXCR4 desensitization or a single dose of AMD3100 remain in the peripheral circulation. As the treatment effects wear off, cells exit the circulation. Error bars in k and l represent s.e.m. Scale bars in a-j, 100 mm. applicable to the study of these and other molecules (see Supplementary Figs 8 and 9) .
We do not yet know whether the observed patterns of molecular expression represent a response to ongoing signals from adjacent stromal or haematopoietic elements, or whether they reflect embryologic patterning. Although we have focused our studies on the calvarial flat bone, the molecular and functional regionalization of bone marrow vasculature and the ability of these domains to sustain cell engraftment might not be identical in all marrow spaces. As flat and long bones form through different processes (intramembranous versus endochondral ossification), it will be of interest to investigate whether marrow cavities that arise through different developmental pathways show unique molecular patterning of the vasculature.
As these bone marrow vascular gateways also appear to denote favourable environments for tumour engraftment, their targeted blockade could protect the marrow from continued metastasis in settings where residual disease is suspected. Greater understanding of how these regions might foster cell growth, and whether malignant and benign cells compete for entry or survival within bone marrow microdomains, could thus provide new targets for intervention in the treatment of metastatic disease.
METHODS
BALB/c or SCID mice were anesthetized and a small incision made in the scalp so as to expose the underlying dorsal skull surface. For cell tracking, 5 £ 10 6 leukaemic cells labelled with the fluorescent lipophilic tracers DiD or DiR (Molecular Probes) were injected into the tail vein. Leukaemic cell homing to bone marrow vasculature of the skull was then imaged using a custom-built fluorescence confocal/multiphoton microscope while the mice were under anaesthesia on a warmed microscope stage. For in vivo immunofluorescence imaging, antibodies were either purchased as fluorescent conjugates or were conjugated to fluorescent cyanine compounds (Amersham) or to AlexaFluor750 (Molecular Probes) according to the manufacturers' protocols. Labelled antivascular cell adhesion or isotype control antibodies were injected into mice through the tail vein at doses of 0.5-1 mg kg 21 . Approximately 24 h were allowed to elapse before imaging in order to maximize antibody binding and clearance of unbound label from the circulation. High-resolution images with cellular details were obtained through the intact mouse skull at depths of up to 250 mm from the surface of the skull using an £ 30 0.9NA water immersion objective lens. Quantitative evaluation was made by dividing the bone marrow into pre-determined quadrants and counting the number of fluorescent cells per field.
Please refer to the Supplementary Methods for descriptions of the imaging system and the in vivo flow cytometer, and for additional information on cell purification, cell labelling, vascular CAM immunostaining, serial imaging, colocalization, quantitative PCR, chemotaxis assays, CXCR4 desensitization by SDF-1 and CXCR4 blockade by AMD3100.
